Literature DB >> 32585314

Recognition of physiological phosphorylation sites by p21-activated kinase 4.

Ashwin K Chetty1, Joel A Sexton2, Byung Hak Ha2, Benjamin E Turk3, Titus J Boggon4.   

Abstract

Many serine/threonine protein kinases discriminate between serine and threonine substrates as a filter to control signaling output. Among these, the p21-activated kinase (PAK) group strongly favors phosphorylation of Ser over Thr residues. PAK4, a group II PAK, almost exclusively phosphorylates its substrates on serine residues. The only well documented exception is LIM domain kinase 1 (LIMK1), which is phosphorylated on an activation loop threonine (Thr508) to promote its catalytic activity. To understand the molecular and kinetic basis for PAK4 substrate selectivity we compared its mode of recognition of LIMK1 (Thr508) with that of a known serine substrate, β-catenin (Ser675). We determined X-ray crystal structures of PAK4 in complex with synthetic peptides corresponding to its phosphorylation sites in LIMK1 and β-catenin to 1.9 Å and 2.2 Å resolution, respectively. We found that the PAK4 DFG + 1 residue, a key determinant of phosphoacceptor preference, adopts a sub-optimal orientation when bound to LIMK1 compared to β-catenin. In peptide kinase activity assays, we find that phosphoacceptor identity impacts catalytic efficiency but does not affect the Km value for both phosphorylation sites. Although catalytic efficiency of wild-type LIMK1 and β-catenin are equivalent, T508S mutation of LIMK1 creates a highly efficient substrate. These results suggest suboptimal phosphorylation of LIMK1 as a mechanism for controlling the dynamics of substrate phosphorylation by PAK4.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crystallography; Kinase; LIM domain kinase; Ste20 kinase; Substrate specificity; β-Catenin

Mesh:

Substances:

Year:  2020        PMID: 32585314      PMCID: PMC7395882          DOI: 10.1016/j.jsb.2020.107553

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  62 in total

Review 1.  Understanding and exploiting substrate recognition by protein kinases.

Authors:  Benjamin E Turk
Journal:  Curr Opin Chem Biol       Date:  2008-03-07       Impact factor: 8.822

2.  Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.

Authors:  Byung Hak Ha; Matthew J Davis; Catherine Chen; Hua Jane Lou; Jia Gao; Rong Zhang; Michael Krauthammer; Ruth Halaban; Joseph Schlessinger; Benjamin E Turk; Titus J Boggon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

3.  PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis.

Authors:  Hai-Tao Xu; Wai-Lung Lai; Heong-Fai Liu; Leo Lap-Yan Wong; Irene Oi-Lin Ng; Yick Pang Ching
Journal:  Cancer Res       Date:  2016-08-05       Impact factor: 12.701

Review 4.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

5.  Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase.

Authors:  M Maekawa; T Ishizaki; S Boku; N Watanabe; A Fujita; A Iwamatsu; T Obinata; K Ohashi; K Mizuno; S Narumiya
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

6.  p120-catenin is a binding partner and substrate for Group B Pak kinases.

Authors:  Lisa Epstein Wong; Albert B Reynolds; Nadishani T Dissanayaka; Audrey Minden
Journal:  J Cell Biochem       Date:  2010-08-01       Impact factor: 4.429

7.  Activation of LIM kinases by myotonic dystrophy kinase-related Cdc42-binding kinase alpha.

Authors:  T Sumi; K Matsumoto; A Shibuya; T Nakamura
Journal:  J Biol Chem       Date:  2001-05-04       Impact factor: 5.157

8.  Pak4 induces premature senescence via a pathway requiring p16INK4/p19ARF and mitogen-activated protein kinase signaling.

Authors:  Marta S Cammarano; Tanya Nekrasova; Beatrice Noel; Audrey Minden
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

9.  PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis.

Authors:  Q Guo; N Su; J Zhang; X Li; Z Miao; G Wang; M Cheng; H Xu; L Cao; F Li
Journal:  Oncogene       Date:  2013-07-29       Impact factor: 9.867

10.  Identification of a major determinant for serine-threonine kinase phosphoacceptor specificity.

Authors:  Catherine Chen; Byung Hak Ha; Anastasia F Thévenin; Hua Jane Lou; Rong Zhang; Kevin Y Yip; Jeffrey R Peterson; Mark Gerstein; Philip M Kim; Panagis Filippakopoulos; Stefan Knapp; Titus J Boggon; Benjamin E Turk
Journal:  Mol Cell       Date:  2013-12-26       Impact factor: 17.970

View more
  1 in total

Review 1.  Structural Aspects of LIMK Regulation and Pharmacology.

Authors:  Deep Chatterjee; Franziska Preuss; Verena Dederer; Stefan Knapp; Sebastian Mathea
Journal:  Cells       Date:  2022-01-02       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.